Association between serum osteocalcin and insulin resistance in postmenopausal, but not premenopausal, women in Korea

Menopause

Volumn 20, Issue 10, 2013, Pages 1061-1066

  Kim, Sue ^a   Lee, Jee Yon ^a   Im, Jee Aee ^b   Kim, Dong Wook ^c   Lee, Hye Sun ^c   Kim, Sang Hwan ^d   Lee, Ji Won ^a  

^a Yonsei University College of Medicine   (South Korea)

^b INTOTO Inc   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Kwandong University College of Medicine   (South Korea)

Author keywords

Insulin resistance; Osteocalcin; Postmenopause; Premenopause

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; INSULIN; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KOREA; MAJOR CLINICAL STUDY; MENOPAUSE; OBESITY; POSTMENOPAUSE; PREMENOPAUSE;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; OSTEOCALCIN; POSTMENOPAUSE; PREMENOPAUSE; REPUBLIC OF KOREA;

EID: 84885184543     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e31828838e8     Document Type: Article

References (44)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. South Med J 2001;94: 569-573.
2. Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia 2011;54: 1291-1297.
3. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130: 456-469.
4. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates A cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A 2008; 105: 5266-5270.
5. Fernandez-Real JM, Izquierdo M, Ortega F, et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 2009;94: 237-245.
6. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009;94: 827-832.
7. Hwang YC, Jeong IK, Ahn KJ, Chung HY. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced A-cell function in middle-aged male subjects. Diabetes Metab Res Rev 2009;25: 768-772.
8. Iki M, Tamaki J, Fujita Y, et al. Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos Int 2012;23: 761-770.
9. Saleem U, Mosley TH Jr, Kullo IJ. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 2010;30: 1474-1478.
10. Kim SH, Lee JW, Im JA, Hwang HJ. Serum osteocalcin is related to abdominal obesity in Korean obese and overweight men. Clin Chim Acta 2010;411: 2054-2057.
11. Yeap BB, Chubb SA, Flicker L, et al. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol 2010;163: 265-272.
12. Bao Y, Zhou M, Lu Z, et al. Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men. Clin Endocrinol (Oxf) 2011;75: 196-201.
13. Bae SJ, Choe JW, Chung YE, et al. The association between serum osteocalcin levels and metabolic syndrome in Koreans. Osteoporos Int 2011;22: 2837-2846.
14. Tan A, Gao Y, Yang X, et al. Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey. Metabolism 2011;60: 1186-1192.
15. Oosterwiff MM, van Schoor NM, Lips P, Eekhoff EM. Osteocalcin as a predictor of the metabolic syndrome in older persons: a population-based study. Clin Endocrinol (Oxf) 2013;78: 242-247.
16. Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 2012;50: 568-575.
17. Rosano GM, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climacteric 2007;10(Suppl 1): 19-24.
18. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88: 2404-2411.
19. Eastell R, Hannon RA. Biomarkers of bone health and osteoporosis risk. Proc Nutr Soc 2008;67: 157-162.
20. Atalay S, Elci A, Kayadibi H, Onder CB, Aka N. Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women. Ann Lab Med 2012;32: 23-30.
21. Lee SW, Jo HH, Kim MR, You YO, Kim JH. Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women. Gynecol Endocrinol 2012;28: 472-477.
22. Garcia-Martin A, Cortes-Berdonces M, Luque-Fernandez I, Rozas- Moreno P, Quesada-Charneco M, Munoz-Torres M. Osteocalcin as a marker of metabolic risk in healthy postmenopausal women. Menopause 2011;18: 537-541.
23. Im JA, Yu BP, Jeon JY, Kim SH. Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta 2008; 396: 66-69.
24. Miller PD. Guidelines for the diagnosis of osteoporosis: T-scores vs fractures. Rev Endocr Metab Disord 2006;7: 75-89.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and A-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419.
26. D'Agostino RB Jr Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17: 2265-2281.
27. Nimptsch K, Hailer S, Rohrmann S, Gedrich K, Wolfram G, Linseisen J. Determinants and correlates of serum undercarboxylated osteocalcin. Ann Nutr Metab 2007;51: 563-570.
28. Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med 2007;26: 734-753.
29. Austin PC, Mamdani MM. A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use. Stat Med 2006;25: 2084-2106.
30. Gayat E, Pirracchio R, Resche-Rigon M, Mebazaa A, Mary JY, Porcher R. Propensity scores in intensive care and anaesthesiology literature: a systematic review. Intensive Care Med 2010;36: 1993-2003.
31. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143: 29-36.
32. Nunez E, Steyerberg EW, Nunez J. [Regression modeling strategies]. Rev Esp Cardiol 2011;64: 501-507.
33. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley and Sons, Inc, 1989.
34. Akune T, Ohba S, Kamekura S, et al. PPARF insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004;113: 846-855.
35. Petzel M. Action of leptin on bone and its relationship to menopause. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007;151: 195-199.
36. Fulzele K, Riddle RC, DiGirolamo DJ, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010;142: 309-319.
37. Liu SZ, Tian LF, Xu P, et al. Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women. Mol Biol Rep 2011;38: 939-948.
38. Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Berman DM. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 2002;87: 4166-4170.
39. Tobias JH, Compston JE. Does estrogen stimulate osteoblast function in postmenopausal women? Bone 1999;24: 121-124.
40. Zhou M, Ma X, Li H, et al. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol 2009;161: 723-729.
41. Bullo M, Moreno-Navarrete JM, Fernandez-Real JM, Salas-Salvado J. Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and A cell function in elderly men at high cardiovascular risk. Am J Clin Nutr 2012;95: 249-255.
42. Pirracchio R, Resche-Rigon M, Chevret S. Evaluation of the propensity score methods for estimating marginal odds ratios in case of small sample size. BMC Med Res Methodol 2012;12: 70.
43. Yokoyama H, Emoto M, Fujiwara S, et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. J Clin Endocrinol Metab 2004;89: 1481-1484.
44. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008;294:E15-E26.